The Acadia Healthcare Company Inc (ACHC) Rating Reiterated by KeyCorp

The Acadia Healthcare Company Inc (ACHC) Rating Reiterated by KeyCorp

Several other brokerages have also issued reports on ACHC. Jefferies Group LLC reiterated a “buy” rating on shares of Acadia Healthcare Company in a research note on Monday, May 15th. Mizuho reiterated a “buy” rating and issued a $52.00 price target (up from $45.00) on shares of Acadia Healthcare Company in a research note on Monday, February 27th. Zacks Investment Research upgraded shares of Acadia Healthcare Company from a “sell” rating to a “hold” rating in a research note on Friday, March 24th. Cantor Fitzgerald reiterated a “hold” rating and issued a $45.00 price target on shares of Acadia Healthcare Company in a research note on Wednesday, April 26th. Finally, Deutsche Bank AG started coverage on shares of Acadia Healthcare Company in a research note on Wednesday, April 5th. They issued a “buy” rating and a $53.00 price target for the company. Four research analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Acadia Healthcare Company currently has a consensus rating of “Buy” and a consensus price target of $57.82.

Acadia Healthcare Company Inc (NASDAQ:ACHC)‘s stock had its “overweight” rating reiterated by investment analysts at KeyCorp in a research note issued to investors on Thursday. They presently have a $51.00 price objective on the stock. KeyCorp’s price target indicates a potential upside of 16.73% from the company’s previous close.

Shares of Acadia Healthcare Company (NASDAQ ACHC) opened at 43.69 on Thursday. Acadia Healthcare Company has a 52-week low of $32.54 and a 52-week high of $63.67. The stock’s 50 day moving average is $43.41 and its 200 day moving average is $40.48. The company has a market capitalization of $3.84 billion, a P/E ratio of 254.01 and a beta of 0.91.

Acadia Healthcare Company (NASDAQ:ACHC) last issued its quarterly earnings results on Tuesday, April 25th. The company reported $0.46 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.46. The company had revenue of $679.20 million during the quarter, compared to analyst estimates of $691.74 million. Acadia Healthcare Company had a net margin of 0.22% and a return on equity of 8.91%. Acadia Healthcare Company’s quarterly revenue was up 10.1% compared to the same quarter last year. During the same period last year, the business earned $0.55 EPS. Equities analysts expect that Acadia Healthcare Company will post $2.44 EPS for the current year.

In other Acadia Healthcare Company news, VP Randall P. Goldberg sold 4,925 shares of the firm’s stock in a transaction dated Thursday, May 4th. The shares were sold at an average price of $45.18, for a total transaction of $222,511.50. Following the completion of the sale, the vice president now directly owns 10,607 shares in the company, valued at approximately $479,224.26. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, COO Ronald Morgan Fincher sold 86,483 shares of the firm’s stock in a transaction dated Monday, May 1st. The shares were sold at an average price of $44.43, for a total transaction of $3,842,439.69. Following the sale, the chief operating officer now owns 137,204 shares of the company’s stock, valued at $6,095,973.72. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 92,322 shares of company stock valued at $4,104,756. 17.20% of the stock is owned by company insiders.

Several hedge funds have recently made changes to their positions in the company. Seven Eight Capital LP bought a new stake in shares of Acadia Healthcare Company during the fourth quarter worth approximately $152,000. Emerald Mutual Fund Advisers Trust bought a new stake in shares of Acadia Healthcare Company during the first quarter worth approximately $210,000. Paloma Partners Management Co bought a new stake in shares of Acadia Healthcare Company during the first quarter worth approximately $217,000. Pacad Investment Ltd. bought a new stake in shares of Acadia Healthcare Company during the fourth quarter worth approximately $166,000. Finally, M&T Bank Corp bought a new stake in shares of Acadia Healthcare Company during the first quarter worth approximately $230,000. Acadia Healthcare Company Company Profile

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.new TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “NASDAQ:ACHC”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Related posts

Leave a Comment